DalsnaFinance › IPOs › Seaport Therapeutics › IPO
Seaport Therapeutics, Inc. completed its initial public offering on NASDAQ on May 1, 2026, pricing at $18.00 a share.
| Ticker | SPTX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 1, 2026 |
| Offering price | $18.00 |
| Shares offered | 14,160,000 |
| Total raised | $255M |
Seaport Therapeutics, Inc. sold 14,160,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $254.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $255 million total recorded for the deal.
Measured by money raised, Seaport Therapeutics, Inc. was tied for the 118th largest (level with 1 other deal) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 70th largest (level with 1 other listing).
May 2026 saw 28 completed IPOs in the site's data; by amount raised, Seaport Therapeutics, Inc. was the 9th largest of the 21 deals with a recorded size.
Its $18.00 offer price was tied for the 82nd highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Seaport Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Seaport Therapeutics, Inc.. This page is general information, not investment advice.